ICU Medical
ICUI
156.03
-3.70
-2.32%
ICU Medical
US · ICUI
#2287 by market cap
Listed 1970
156.03
-3.70
-2.32%
Live - 5344 symbols - heartbeat 194s ago
· 2026-10-07 19:54
After-hours
156.03
0.00%
- Market cap
- 3.90B
- P/E (TTM)i
- 131.12
- P/Bi
- 1.81
- EPSi
- 0.03
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on ICUI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.1 percentage points.
Institutional ownership
- Held by institutions
- 105.31% -0.11pp
- Institutions
- 342 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund91.95%
Public Company5.50%
Hedge Fund4.98%
Individual/Insider1.77%
Government Pension Fund1.46%
Sovereign Wealth Fund0.71%
Private Company0.44%
Insurance Company0.17%
Top holders as of 2026-06-30
BlackRock
15.01% · 3.75M sh
Janus Henderson Group plc
11.12% · 2.78M sh
Vanguard Portfolio Management, LLC
5.88% · 1.47M sh
Fuller & Thaler Asset Management, Inc.
5.19% · 1.30M sh
Vanguard Capital Management, LLC
5.16% · 1.29M sh
Dimensional Fund Advisors
4.21% · 1.05M sh
State Street Global Advisors
4.10% · 1.02M sh
Schroder Investment Management North America Inc.
2.88% · 720.64K sh
Columbia Management Investment Advisers, LLC
2.76% · 689.57K sh
Geode Capital Management, LLC
2.64% · 660.42K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 26 sells
| Name | Role | Stake |
|---|---|---|
| Vivek Jain | Chairperson & CEO | 1.12% |
| Brian Bonnell | Chief Financial Officer | 0.22% |
| Christian Voigtlander | Chief Operating Officer | 0.15% |
| Daniel Woolson | Former Corporate VP & GM of Infusion Systems | 0.07% |
| Virginia Sanzone | Corporate VP, General Counsel, Secretary & Compliance Officer | 0.06% |
| David Greenberg | Lead Independent Director | 0.04% |
| David Hoffmeister | Independent Director | 0.02% |
| Donald Abbey | Independent Director | 0.02% |
| Elisha Finney | Independent Director | 0.02% |
| Laurie Hernandez | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-02 | Virginia Sanzone | Corporate VP, General Counsel, Secretary & Compliance Officer | Automatic Disposition | -4,856 | $167.67–171.52 |
| 2026-08-31 | Brian Bonnell | Chief Financial Officer | Automatic Disposition | -6,381 | $175.00 |
| 2026-08-30 | Brian Bonnell | Chief Financial Officer | Automatic Disposition | -9,307 | $171.05–173.91 |
| 2026-08-12 | Daniel Woolson | Former Corporate VP & GM of Infusion Systems | Open Market Disposition | -5,417 | $181.33 |
| 2026-08-11 | Ben Sousa | Chief Information Officer | Open Market Disposition | -2,250 | $178.32 |
| 2026-08-10 | Elisha Finney | Independent Director | Open Market Disposition | -378 | $182.48 |
| 2026-08-10 | Christian Voigtlander | Chief Operating Officer | Open Market Disposition | -8,929 | $182.93 |
| 2026-05-21 | Daniel Woolson | Former Corporate VP & GM of Infusion Systems | Open Market Disposition | -2,123 | $132.21 |
| 2026-05-13 | Virginia Sanzone | Corporate VP, General Counsel, Secretary & Compliance Officer | Open Market Disposition | -2,447 | $124.08 |
| 2026-05-12 | Elisha Finney | Independent Director | Other Derivative Acquisition | +1,475 | -- |
| 2026-05-12 | Elisha Finney | Independent Director | Derivative Exercise and Retained | +1,254 | -- |
| 2026-05-12 | Kolleen Kennedy | Independent Director | Other Derivative Acquisition | +1,475 | -- |
| 2026-05-12 | Kolleen Kennedy | Independent Director | Derivative Exercise and Retained | +1,254 | -- |
| 2026-05-12 | David Hoffmeister | Independent Director | Other Derivative Acquisition | +1,475 | -- |
| 2026-05-12 | David Hoffmeister | Independent Director | Derivative Exercise and Retained | +1,254 | -- |
| 2026-05-12 | Laurie Hernandez | Independent Director | Other Derivative Acquisition | +1,475 | -- |
| 2026-05-12 | Laurie Hernandez | Independent Director | Derivative Exercise and Retained | +1,254 | -- |
| 2026-05-12 | David Greenberg | Lead Independent Director | Other Derivative Acquisition | +1,475 | -- |
| 2026-05-12 | David Greenberg | Lead Independent Director | Derivative Exercise and Retained | +1,254 | -- |
| 2026-05-12 | Donald Abbey | Independent Director | Other Derivative Acquisition | +1,475 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.